Marianne Canonico is a biologist and an endocrinologist. She carried out her thesis at the University Paris XI and then followed an additional training on epidemiology and clinical research. Between 2004 and 2009, she worked as a postdoc fellow within the team “Hormones and Vessels” of the National Institute of Health and Medical Research (Inserm) Unit 780 and also worked within the Cancer Epidemiology Unit (Oxford University) for one year. In 2009, she was recruited at the Inserm as a Research Associate and now participates in the “Hormones and Cardiovascular disease” team (coordinator: Pierre-Yves Scarabin) within the Center of Epidemiology and Population Health (Inserm UMR-S 1018) at Villejuif.
The research area of Marianne Canonico focuses on the hormonal determinants of cardiovascular disease. She investigates the impact of postmenopausal hormone replacement therapy on the risk of venous thromboembolism from the data of several epidemiological studies. Most importantly, she already emphasized that both route of estrogens administration and progestogens were important determinants of the thrombotic risk among postmenopausal women. She now expands her research to arterial disease investigating the role of postmenopausal hormone therapy on cerebral disease. She also studies the impact of endogenous steroid sex hormones on arterial ischemic disease among women in the elderly taking into account the hormones genetic variability.